ID   TD-2
AC   CVCL_A6UC
SY   TD2
DR   Wikidata; Q107117015
RX   PubMed=12454861;
RX   PubMed=14555993;
RX   PubMed=16230077;
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
CC   Breed/subspecies: C57BL/6J x BALB/cJ TGFalpha/Trp53(+/-) transgenic.
DI   NCIt; C34035; Mouse pancreatic neoplasm
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
SX   Male
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 29-06-23; Version: 4
//
RX   PubMed=12454861; DOI=10.1053/gast.2002.37075;
RA   Greten F.R., Weber C.K., Greten T.F., Schneider G., Wagner M.,
RA   Adler G., Schmid R.M.;
RT   "Stat3 and NF-kappaB activation prevents apoptosis in pancreatic
RT   carcinogenesis.";
RL   Gastroenterology 123:2052-2063(2002).
//
RX   PubMed=14555993; DOI=10.1038/sj.onc.1206836;
RA   Schreiner B., Greten F.R., Baur D.M., Fingerle A.A., Zechner U.,
RA   Bohm C., Schmid M., Hameister H., Schmid R.M.;
RT   "Murine pancreatic tumor cell line TD2 bears the characteristic
RT   pattern of genetic changes with two independently amplified gene
RT   loci.";
RL   Oncogene 22:6802-6809(2003).
//
RX   PubMed=16230077; DOI=10.1053/j.gastro.2005.06.056;
RA   Saur D., Seidler B., Schneider G., Algul H., Beck R.,
RA   Senekowitsch-Schmidtke R., Schwaiger M., Schmid R.M.;
RT   "CXCR4 expression increases liver and lung metastasis in a mouse model
RT   of pancreatic cancer.";
RL   Gastroenterology 129:1237-1250(2005).
//